TrialSignal transduction and targeted therapy2025

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial.

Ming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.